<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01308892</url>
  </required_header>
  <id_info>
    <org_study_id>NL33506.081.10</org_study_id>
    <nct_id>NCT01308892</nct_id>
  </id_info>
  <brief_title>Cardiovascular Health Effects of Flavanol Rich Chocolate</brief_title>
  <acronym>CHOC</acronym>
  <official_title>Cardiovascular Health Effects of Flavanol Rich Chocolate</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Wageningen University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Top Institute Food and Nutrition</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Wageningen University</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      In the CHOC study the investigators will examine the effect of chocolate flavanols on
      vascular function, inflammation, oxidative stress and markers of endothelial function. The
      effects of both acute consumption and prolonged consumption will be studied. The secondary
      objectives are to investigate if daily intake of chocolate flavanols for 4 weeks will improve
      the response to a high fat/high energy challenge.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>January 2011</start_date>
  <completion_date type="Actual">June 2011</completion_date>
  <primary_completion_date type="Actual">June 2011</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Crossover Assignment</intervention_model>
    <masking>Double (Participant, Investigator)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Blood pressure</measure>
    <time_frame>0, 4wk</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>FMD</measure>
    <time_frame>0, 4wk</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>PWA</measure>
    <time_frame>0, 4wk</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>leukocyte count and activation</measure>
    <time_frame>0, 4wk</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>PBMC gene expression</measure>
    <time_frame>0, 4wk</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Markers of inflammation and ED</measure>
    <time_frame>0, 4wk</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Blood pressure</measure>
    <time_frame>0 and 2h</time_frame>
    <description>acute study part</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>FMD</measure>
    <time_frame>0 and 2hrs</time_frame>
    <description>acute study part</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>PWA</measure>
    <time_frame>0 and 2 hrs</time_frame>
    <description>acute study part</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Leukocyte count and activation</measure>
    <time_frame>0 and 2 hrs</time_frame>
    <description>acute study part</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>PBMC gene expression</measure>
    <time_frame>0 and 2 hrs</time_frame>
    <description>acute study part</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>markers of inflammation and ED</measure>
    <time_frame>0 and 2hrs</time_frame>
    <description>acute study part</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">44</enrollment>
  <condition>Endothelial Dysfunction</condition>
  <arm_group>
    <arm_group_label>High flavaonol chocolate</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
  </arm_group>
  <arm_group>
    <arm_group_label>Low flavanol chocolate</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
  </arm_group>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>High flavanol chocolate</intervention_name>
    <description>chocolate high in flavanols</description>
    <arm_group_label>High flavaonol chocolate</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>Low flavanol chocolate</intervention_name>
    <description>chocolate low in flavanols</description>
    <arm_group_label>Low flavanol chocolate</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>High fat challenge</intervention_name>
    <description>Milkshake with 95g fat</description>
    <arm_group_label>High flavaonol chocolate</arm_group_label>
    <arm_group_label>Low flavanol chocolate</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Male

          -  45-70 years old

          -  BMI between 25 and 32 kg/m2

        Exclusion Criteria:

          -  Urine glucose concentrations outside normal ranges (&gt; 0,25 g/l)

          -  Fasting blood glucose &lt; 7.0 mmol/L)

          -  Systolic Bp &gt; 160 mmHg or diastolic Bp &gt; 100 mmHg

          -  Blood Hb values below 8.4 mmol/L

          -  Allergic to cow milk, dairy products or chocolate

          -  Vegetarian

          -  Tobacco smoker

          -  Diagnosed with any long-term medical condition (e.g., diabetes, hemophilia,
             cardiovascular disease, anemia, gastrointestinal disease, renal failure)
      </textblock>
    </criteria>
    <gender>Male</gender>
    <minimum_age>45 Years</minimum_age>
    <maximum_age>70 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Michael MÃ¼ller, Prof.Dr</last_name>
    <role>Study Chair</role>
    <affiliation>Chair Department of human nutrition NMG group</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Wageningen universiteit division of human</name>
      <address>
        <city>Wageningen</city>
        <state>Gelderland</state>
        <zip>6703HD</zip>
        <country>Netherlands</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Netherlands</country>
  </location_countries>
  <verification_date>June 2011</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>February 15, 2011</study_first_submitted>
  <study_first_submitted_qc>March 3, 2011</study_first_submitted_qc>
  <study_first_posted type="Estimate">March 4, 2011</study_first_posted>
  <last_update_submitted>June 16, 2011</last_update_submitted>
  <last_update_submitted_qc>June 16, 2011</last_update_submitted_qc>
  <last_update_posted type="Estimate">June 17, 2011</last_update_posted>
  <responsible_party>
    <name_title>Wageningen universiteit department of human nutrition</name_title>
    <organization>Wageningen University</organization>
  </responsible_party>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

